Emergence of mcr-1 mediated colistin resistant Escherichia coli from a hospitalized patient in Bangladesh. 2019

Refath Farzana, and Lim S Jones, and Md Anisur Rahman, and Mark A Toleman, and Kirsty Sands, and Edward Portal, and Ian Boostrom, and Md Abul Kalam, and Brekhna Hassan, and Akm Nasir Uddin, and Timothy R Walsh
School of Medicine, Department of Medical Microbiology, Institute of Infection and Immunity, Cardiff University, Cardiff, United Kingdom. farzanar@cardiff.ac.uk.

The emergence of plasmid mediated mcr in bacteria has become global public health threat. Herein, we report a mcr-1 positive E. coli in normal human flora from a patient admitted in Dhaka Medical College Hospital (DMCH). In total, 700 non-duplicate rectal swabs were collected from DMCH during 13th May to 12th June 2018. E. coli from rectal swabs were isolated on chromogenic UTI media containing vancomycin 10mg/l (Liofilchem, Italy) and confirmed by MALDI-TOF. Minimum inhibitory concentrations (MIC) were determined by agar dilution and interpreted according to EUCAST breakpoints. Genomic analysis of mcr positive E. coli (MCRPEC) was performed by Illumina MiSeq sequencing and pulsed field gel electrophoresis (PFGE) using S1 nuclease DNA digests and blamcr-1 probing. Transferability of blamcr-1 were determined by conjugation assays. We found one MCRPEC from 700 rectal swab screening which was isolated from the rectal swab culture of a 17-year boy who was admitted to the burns ICU, DMCH with 53% flame burn involving much of the trunk and face. Genome sequencing revealed that mcr-1 was present on an IncH12 plasmid of 257,243 bp and flanked by ISApaI1. The colistin resistance can be transferred to the recipient Klebsiella varricola with a frequency of 8.3 × 10-5. Transconjugants were more resistant to colistin than donor (MIC 32 µg/mL). This is the first human associated mcr in Bangladesh. These data indicate the need for a systematic "one health" surveillance in the country.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D003091 Colistin Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally. Polymyxin E,Colimycin,Colisticin,Colistin Sulfate,Coly-Mycin,Totazina,Sulfate, Colistin
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D006761 Hospitals Institutions with an organized medical staff which provide medical care to patients. Hospital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001459 Bangladesh A country in Southern Asia, bordering the Bay of Bengal, between Burma and India. The capital is Dhaka.
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Refath Farzana, and Lim S Jones, and Md Anisur Rahman, and Mark A Toleman, and Kirsty Sands, and Edward Portal, and Ian Boostrom, and Md Abul Kalam, and Brekhna Hassan, and Akm Nasir Uddin, and Timothy R Walsh
November 2018, The Science of the total environment,
Refath Farzana, and Lim S Jones, and Md Anisur Rahman, and Mark A Toleman, and Kirsty Sands, and Edward Portal, and Ian Boostrom, and Md Abul Kalam, and Brekhna Hassan, and Akm Nasir Uddin, and Timothy R Walsh
June 2016, International journal of antimicrobial agents,
Refath Farzana, and Lim S Jones, and Md Anisur Rahman, and Mark A Toleman, and Kirsty Sands, and Edward Portal, and Ian Boostrom, and Md Abul Kalam, and Brekhna Hassan, and Akm Nasir Uddin, and Timothy R Walsh
October 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Refath Farzana, and Lim S Jones, and Md Anisur Rahman, and Mark A Toleman, and Kirsty Sands, and Edward Portal, and Ian Boostrom, and Md Abul Kalam, and Brekhna Hassan, and Akm Nasir Uddin, and Timothy R Walsh
January 2017, Gut pathogens,
Refath Farzana, and Lim S Jones, and Md Anisur Rahman, and Mark A Toleman, and Kirsty Sands, and Edward Portal, and Ian Boostrom, and Md Abul Kalam, and Brekhna Hassan, and Akm Nasir Uddin, and Timothy R Walsh
October 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Refath Farzana, and Lim S Jones, and Md Anisur Rahman, and Mark A Toleman, and Kirsty Sands, and Edward Portal, and Ian Boostrom, and Md Abul Kalam, and Brekhna Hassan, and Akm Nasir Uddin, and Timothy R Walsh
March 2019, Journal of global antimicrobial resistance,
Refath Farzana, and Lim S Jones, and Md Anisur Rahman, and Mark A Toleman, and Kirsty Sands, and Edward Portal, and Ian Boostrom, and Md Abul Kalam, and Brekhna Hassan, and Akm Nasir Uddin, and Timothy R Walsh
April 2024, Foodborne pathogens and disease,
Refath Farzana, and Lim S Jones, and Md Anisur Rahman, and Mark A Toleman, and Kirsty Sands, and Edward Portal, and Ian Boostrom, and Md Abul Kalam, and Brekhna Hassan, and Akm Nasir Uddin, and Timothy R Walsh
May 2016, Antimicrobial agents and chemotherapy,
Refath Farzana, and Lim S Jones, and Md Anisur Rahman, and Mark A Toleman, and Kirsty Sands, and Edward Portal, and Ian Boostrom, and Md Abul Kalam, and Brekhna Hassan, and Akm Nasir Uddin, and Timothy R Walsh
April 2016, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Refath Farzana, and Lim S Jones, and Md Anisur Rahman, and Mark A Toleman, and Kirsty Sands, and Edward Portal, and Ian Boostrom, and Md Abul Kalam, and Brekhna Hassan, and Akm Nasir Uddin, and Timothy R Walsh
March 2018, Journal of global antimicrobial resistance,
Copied contents to your clipboard!